Pharmacologic Treatment for Temporomandibular and Temporomandibular Joint Disorders
| Autor: | Joseph Kang, Harry Dym, Amanda Andre |
|---|---|
| Rok vydání: | 2022 |
| Předmět: |
musculoskeletal diseases
medicine.medical_treatment Injections Intra-Articular Pharmacological treatment chemistry.chemical_compound Pharmacotherapy stomatognathic system medicine Temporomandibular Joint Disorder Humans Hyaluronic Acid Nonsteroidal Temporomandibular Joint business.industry Prolotherapy Temporomandibular Joint Disorders Botulinum toxin Temporomandibular joint stomatognathic diseases medicine.anatomical_structure Otorhinolaryngology chemistry Anesthesia Anticonvulsants Surgery Oral Surgery business medicine.drug |
| Zdroj: | Oral and Maxillofacial Surgery Clinics of North America. 34:49-59 |
| ISSN: | 1042-3699 |
| Popis: | Temporomandibular joint disorder is defined by pain and/or loss of function of the temporomandibular joint and its associated muscles and structures. Treatments include noninvasive pharmacologic therapies, minimally invasive muscular and articular injections, and surgery. Conservative therapies include nonsteroidal anti-inflammatory drugs, muscle relaxants, benzodiazepines, antidepressants, and anticonvulsants. Minimally invasive injections include botulinum toxin, corticosteroids, platelet-rich plasma, hyaluronic acid, and prolotherapy with hypertonic glucose. With many pharmacologic treatment options and modalities available to the oral and maxillofacial surgeon, mild to moderate temporomandibular joint disorder can be managed safely and effectively to improve symptoms of pain and function of the temporomandibular joint. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|